Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials - Kishi, T; Mukai, T; Matsuda, Y (J Psychiatr Res, 2013)
et al.